Show simple item record

dc.contributor.authorWorld Health Organization
dc.coverage.spatialGenevaen_US
dc.date.accessioned2017-11-01T12:40:30Z
dc.date.available2017-11-01T12:40:30Z
dc.date.issued2017
dc.identifier.govdocWHO/HTM/NTD/PCT/2017.07
dc.identifier.isbn9789241550161
dc.identifier.urihttps://apps.who.int/iris/handle/10665/259381
dc.description50 p.en_US
dc.language.isoenen_US
dc.publisherWorld Health Organizationen_US
dc.rightsCC BY-NC-SA 3.0 IGOen_US
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/3.0/igoen_US
dc.subjectWHO guidelineen_US
dc.subject.meshFilariasisen_US
dc.subject.meshElephantiasis, Filarialen_US
dc.subject.meshGuidelineen_US
dc.subject.meshNeglected Diseasesen_US
dc.subject.meshAnthelminticsen_US
dc.subject.meshDrug Therapy
dc.titleGuideline: alternative mass drug administration regimens to eliminate lymphatic filariasisen_US
dc.typePublicationsen_US
dc.subject.meshqualifierdrug therapyen_US
dc.subject.meshqualifieradministration and dosageen_US
dc.subject.meshqualifiermethods
dc.rights.holderWorld Health Organizationen_US


Files in this item

Thumbnail

This item appears in the following Collection(‎s)‎

Show simple item record